https://www.avient.com/sites/default/files/2022-04/Sustainable Material Answers_ Recycled PET 2022.pdf
SHEET
RAW MATERIAL
SUPPLIERS
PET BOTTLE
PET PREFORM
THERMOFORMERS BRAND
OWNERS
RETAILERS
CONSUMERS
LOCAL WASTE
MANAGEMENT
SORTING
COMPANIES
RECYCLING
COMPANIES
REGULATION
BODIES
NIAS
COMPLIANT
Why is PET
so Popular?
Sheet & Film—Sheets and films made
of PET are another major use case.
PET
sheets can be used to make a variety of
plastic products and film is often used
for tape backing, plastic wrap, medical
packaging, and protective coating on
windows.
https://www.avient.com/resource-center?document_type=59&page=38
Technical Data Sheets
Safety Data Sheets
Safety Data Sheets
https://www.avient.com/resource-center?document_type=59&document_subtype=0&industry=0&product_family=0&product_name=0&op=FILTER RESULTS&form_id=resource_filter_form&page=38
Technical Data Sheets
Safety Data Sheets
Safety Data Sheets
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520Goldman%2520Sachs%2520Conference%2520-%2520November%25202015.pdf
PolyOne Corporation Page 4
PolyOne Commodity to Specialty Transformation
• Volume driven,
commodity producer
• Heavily tied to
cyclical end markets
• Performance largely
dependent on non-
controlling joint
ventures
2000-2005 2006 - 2009 2010 – 2014 2015 and beyond
• Steve Newlin
appointed, Chairman,
President and CEO
• New leadership team
appointed
• Implementation of four
pillar strategy
• Focus on value based
selling, investment in
commercial resources
and innovation to drive
transformation
• Substantial EPS growth
from $0.13 to all-time
high of $1.80
• Shift to faster growing,
high margin, less
cyclical end markets
• Key acquisitions propel
current and future
growth, as well as
margin expansion
• Specialty mix expands
to 65% of Operating
Income – strongest mix
of earnings in history
• Accelerating growth
• Deliver consistent
double digit annual
EPS growth
• Maintain >35% vitality
index
• Pursue strategic
acquisitions that
expand specialty
offerings and
geographic breadth
• Invest and grow
current and next
generation talent
PolyOne Corporation Page 5
Building &
10%
Electrical &
11%
9%
Distribution
28%
PP&S
Specialty
52%
69%
13%
7% Asia
2014 Revenues: $3.8 Billion
End Markets
2014 Revenues: $3.8 Billion
PolyOne
At A Glance
$0.12
$0.27 $0.21 $0.13
$0.68
$0.82
$1.00
$1.31
$1.80
2006 2007 2008 2009 2010 2011 2012 2013 2014
Adjusted EPS
PolyOne Corporation Page 6
Old
PolyOne
*Operating Income excludes corporate charges and special items
2%
34% 43%
62%
65% 66%
0%
20%
40%
60%
80%
100%
2005 2008 2010 2013 2014 YTD 2015 2020
%
o
f O
pe
ra
tin
g
In
co
m
e*
JV's Performance Products & Solutions Distribution Specialty
80%+
Specialty OI $5M $46M $87M $195M $242M $183M
Mix Shift Highlights Specialty Transformation
Transformation
2020
Platinum
Vision
Platinum
Vision
PolyOne Corporation Page 7
2006 YTD 2015 2020
“Where we were” “Where we are” Platinum Vision
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 17.2% 20%+
Global Specialty Engineered
Materials 1.1% 15.1% 20%+
Designed Structures & Solutions 1.4% (2012) 3.5% 12 – 14%
Performance Products &
Solutions 5.5% 8.1% 10 – 12%
Distribution 2.6% 6.6% 6.5 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 66% 80%+
3) ROIC 5.0% 11.9% 15%
4) Adjusted EPS Growth N/A
24 Consecutive
Quarters of YOY
EPS Growth
Double Digit
Expansion
Proof of Performance & 2020 Goals
PolyOne Corporation Page 8
Innovation Drives Earnings Growth
*Percentage of Specialty Platform revenue from products introduced in last five years
$20
$52
2006 TTM
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
14%
28%
2006 TTM
Specialty Platform
Gross Margin %
12%
43%
2006 TTM
Specialty Vitality Index Target ≥ 35%
TTM 9/30/15 TTM 9/30/15 TTM 9/30/15
PolyOne Corporation Page 9
Innovation Pipeline Potential
Prototype Frame
Opportunity
Scale-up & Test
Market
Build
Business Case
Commercial
Launch
Phase 1 Phase 2 Phase 3 Phase 4 Phase 5
12
4
9
6
1
6
3 7 4
5
6
1
1
7
2
Breakthrough
Platform
Derivative
Number of Projects 12 10 23 19 10 74
Specialty
Addressable Market
($ millions)
- - $1,150 $1,000 $250 $2,400
PolyOne Corporation Page 10
Lightweighting with Advanced Composites
Increasing Healthcare Penetration
Innovation Initiatives
Expansion in Consumer Markets
New Market Development
$$$ $$ $
High Temperature Polymers
PolyOne Corporation Page 11
Design and Service as a Differentiator
Right Material &
Color
Desired
Product Design
Appropriate
Manufacturing Process
Delivering Concept to
Commercialization
Connecting
the Dots with
iQ Design Labs and
InVisiO Color Design
PolyOne Corporation Page 12
Customer First Through World-Class Service
Strengthening relationships through:
Providing LSS services to small/medium sized customers
• Supporting customers who lack their own formal process improvement initiatives
Providing training in Customer Centric Selling Skills with customers’
sales force
PolyOne Corporation Page 13
60%
97%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 Q3 2015
Pension Funding**
As of September 30, 2015
Debt Maturities & Pension Funding
Net Debt / Adjusted EBITDA** = 2.1x
$49
$121
$317
$600
$400
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2018 2020 2023
Debt Maturities
As of September 30, 2015
($ millions)
Coupon Rate: 7.500% Variable* 7.375% 5.250%
** includes US-qualified pension plans only *Weighted average rate on revolver was 2.49% as of 9/30/15 **TTM 9/30/2015
PolyOne Corporation Page 14
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
Expanding our sales,
marketing, and
technical capabilities
Investing in operational
and LSS initiatives
~75% of capital
expenditures fund
growth initiatives Organic
Growth
Acquisitions
Share
Repurchases
Dividends
$0.16
$0.20
$0.32
$0.40
$0.48
$0.10
$0.20
$0.30
$0.40
$0.50
2011 2012 2013 2014 2015 2016
Annual Dividend
Targets that expand
our:
• Specialty offerings
• End market
presence
• Geographic breadth
Synergy opportunities
Adjacent material
solutions
Repurchased nearly
2.4 million shares in Q3
2015
Repurchased 14.8
million shares since
early 2013
5.2 million shares are
available for
repurchase under the
current authorization
$0.24
PolyOne Corporation Page 15
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented in
accordance with U.S.
Trailing twelve months adjusted gross margin is calculated as follows:
Three Months
Nine Months
Trailing Twelve Months
(TTM) Ended
(In millions) December 31, 2014 September 30, 2015 September 30, 2015
Gross margin - GAAP $ 152.6 $ 524.6 $ 677.2
Special items in gross margin 15.8 30.0 45.8
Gross margin excluding special items $ 168.4 $ 554.6 $ 723.0
Adjusted EBITDA and net debt to adjusted EBITDA is calculated as follows:
Three Months
Nine Months
Trailing Twelve
Months (TTM) Ended
(In millions) December 31, 2014 September 30, 2015 September 30, 2015
Income from continuing operations,
before income taxes $ (31.2) $ 168.1 $ 136.9
Interest expense, net 15.6 48.5 64.1
Depreciation and amortization 25.0 78.4 103.4
Special items, impact on income from
continuing operations before income
taxes
80.8 39.8 120.6
Accelerated depreciation included in
special items (0.2) (4.6) (4.8)
Adjusted EBITDA $ 90.0 $ 330.2 $ 420.2
Short-term portion and current portion of
long-term debt $ 61.8
Long-term debt 1,038.0
Less: Cash and cash equivalents (235.7)
Net Debt 864.1
Net Debt/TTM Adjusted EBITDA 2.1
��PolyOne Investor Presentation�Goldman Sachs 2015 US Emerging/�SMID Cap Growth Conference�November 2015��
Forward-Looking Statements
Use of Non-GAAP Measures
PolyOne Commodity to Specialty Transformation
PolyOne�At A Glance
Mix Shift Highlights Specialty Transformation
Proof of Performance & 2020 Goals
Innovation Drives Earnings Growth
Innovation Pipeline Potential
Innovation Initiatives
Design and Service as a Differentiator
Customer First Through World-Class Service
Debt Maturities & Pension Funding
Free Cash Flow and Strong Balance Sheet �Fund Investment / Shareholder Return
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520-%2520Jefferies%2520Industrials%2520Conference%25202015.pdf
S&P 500
PolyOne Corporation Page 9
2006 YTD 2015 2020
“Where we were” “Where we are” Platinum Vision
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 17.2% 20%+
Global Specialty Engineered
Materials 1.1% 15.3% 20%+
Designed Structures & Solutions 1.4% (2012) 3.3% 12 – 14%
Performance Products &
Solutions 5.5% 7.6% 10 – 12%
Distribution 2.6% 6.5% 6.5 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 67% 80%+
3) ROIC (after-tax)* 5.0% 11.7% 15%
4) Adjusted EPS Growth N/A
23 Consecutive
Quarters of YOY
EPS Growth
Double Digit
Expansion
Proof of Performance & 2020 Goals
*ROIC is defined as TTM adjusted operating income after-tax divided by the sum of average debt and equity over a 5 quarter period
PolyOne Corporation Page 10
Platinum Vision: Pathway to Accelerated Growth
Organic
Sales Growth
Margin
Expansion
Share
Repurchases
Acquisitions
PolyOne Corporation Page 11
Innovation Drives Earnings Growth
*Percentage of Specialty Platform revenue from products introduced in last five years
$20
$53
2006 2014
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
14%
27%
2006 2014
Specialty Platform
Gross Margin %
20%
44%
2006 2014
Specialty Vitality Index Target ≥ 35%
PolyOne Corporation Page 12
Megatrends Aligned with Key End Markets
Decreasing
Dependence
on Fossil
Fuels
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
PolyOne Corporation Page 13
Prototype Frame
Opportunity
Scale-up &
Test Market
Build
Business Case
Commercial
Launch
Phase
1
Phase
2
Phase
3
Phase
4
Phase
5
6
9
7
3
5
12
5 3 2
8
4
2
4
3
1
Breakthrough
Platform
Derivative
A Rich Pipeline of Opportunity
Number of Projects 14 8 18 12 22 74
Addressable Market
($ millions) $700 $600 $600 $1,900
PolyOne Corporation Page 14
60%
102%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 Q2 2015
Pension Funding**
As of June 30, 2015
Debt Maturities & Pension Funding
Net Debt / Adjusted EBITDA** = 2.0x
Coupon Rate: 7.500% Variable* 7.375% 5.250%
** includes US-qualified pension plans only *Weighted average rate on revolver was 2.40% as of 6/30/15 **TTM 6/30/2015
$49
$79
$317
$600
$400
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2018 2020 2023
Debt Maturities
As of June 30, 2015
($ millions)
PolyOne Corporation Page 15
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
Expanding our sales,
marketing, and
technical capabilities
Investing in operational
and LSS initiatives
~75% of capital
expenditures fund
growth initiatives Organic
Growth
Acquisitions
Share
Repurchases
Dividends
$0.16
$0.20 $0.24
$0.32
$0.40
$0.10
$0.20
$0.30
$0.40
$0.50
2011 2012 2013 2014 2015
Annual Dividend
Targets that expand
our:
• Specialty offerings
• End market
presence
• Geographic breadth
Synergy opportunities
Adjacent material
solutions
Repurchased nearly
600K shares in Q2
2015
Repurchased 12.4
million shares since
early 2013
7.6 million shares are
available for
repurchase under the
current authorization
PolyOne Corporation Page 16
PolyOne Core Values
Innovation
Collaboration
Excellence
PolyOne Corporation Page 17
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
Schedule I
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented
in accordance with U.S.
Net debt to adjusted EBITDA is calculated as follows:
Six Months
Ended
Twelve Months
Ended Six Months Ended
Trailing Twelve
Months (TTM)
Ended
(In millions) March 31, 2014 December 31, 2014 March 31, 2015 March 31, 2015
Short-term portion and current portion of
long-term debt $ 12.7 $ 61.8 $ 61.8
Long-term debt 967.9 962.0 996.4
Less: Cash and cash equivalents (261.5) (238.6) (236.8)
Net Debt $ 719.1 785.2 821.4
Income before income taxes $ 73.2 $ 88.4 $ 116.7 $ 131.9
Interest expense, net 31.2 62.2 32.3 63.3
Depreciation and amortization 72.2 123.9 50.1 101.8
Special items, impact on operating income 62.2 164.9 21.2 123.9
Accelerated depreciation included in special
items (20.5) (23.1) (0.3) (2.9)
Adjusted EBITDA $ 218.3 $ 416.3 $ 220.0 $ 418.0
Net Debt/TTM Adjusted EBITDA 2.0
POL IR Presentation - Jefferies Industrials Conference 2015 website
��PolyOne Investor Presentation�Jefferies 2015 Industrials Conference�August 2015��
Forward-Looking Statements
Use of Non-GAAP Measures
PolyOne Commodity to Specialty Transformation
PolyOne�At A Glance
Mix Shift Highlights Specialty Transformation
Confirmation of Our Strategy
Strategy and Execution Drive Results
Proof of Performance & 2020 Goals
Platinum Vision: Pathway to Accelerated Growth
Innovation Drives Earnings Growth
Megatrends Aligned with Key End Markets
A Rich Pipeline of Opportunity
Debt Maturities & Pension Funding
Free Cash Flow and Strong Balance Sheet �Fund Investment / Shareholder Return
PolyOne Core Values
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/Lockport_IATF%252016949%25202016_EXP%25205-2021.pdf
Including the following support activities:
PolyOne Design Center (Solution Center)
33567 Walker Road
Avon Lake
Ohio
44012
Audited by ABS QE
Customer service, Marketing, Human resources, Logistics,
Supplier management, Continuous improvement, Info.
https://www.avient.com/sites/default/files/2020-12/packaging-solution-bulletin-selector-guide.pdf
CHEMICAL RESISTANT TPEs ADD FUNCTIONALITY THAT BRINGS VALUE
TO CONSUMERS
• Chemical Resistance – Resists aggressive
soaps, detergents, lotions, oils and solvents
found in cosmetic, personal care and
household products
• Regulatory* – Compositionally compliant
with certain FDA and REACH regulations
• Value – Economical alternative to silicone
and over-engineered medical grade TPEs
• Easy to Process – Can be injection molded
and overmolded right onto the substrate
including PP, ABS, etc
https://www.avient.com/sites/default/files/2024-06/Infant Care Product Bulletin_Selector Guide.pdf
HOW GLS TPES MAKE THE DIFFERENCE IN INFANT CARE APPLICATIONS
• Safe to Use – Made without bisphenol A (BPA),
phthalates, or heavy metals; select grades
compliant with FDA, REACH and China GB4806
• Durable – Resists bites and tears; many are
tested and safe to use in microwaves and
dishwashers
• Comfortable – Can be overmolded to provide a
soft touch grip and customized
to specific comfort requirements including
vibration and noise reduction
• Easy to Process – Can be injection molded and
overmolded right onto a substrate including PP,
ABS, etc
https://www.avient.com/sites/default/files/2023-06/Cesa LM Additives Product Bulletin.pdf
Cesa laser marking solutions can be used with a variety
of thermoplastics including, but not limited to:
• PP
• PC/ABS
• Polyamide
• Polyacetal (POM)
Applications include:
• Traceability, UPC, Branding
• Food Packaging Lot Codes
• Industrial Safety Tags & Equipment
• Wire & Cable Part Numbers & Gauge Size
• Automotive Components
• PE
• PET
• PMMA
• Polyolefins
PRODUCT BULLETIN
WHY LASER MARKING?
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520Specialization.pdf
McAlindon
(24) Page 24
Award-Winning Marketing Campaign
Page 25
2012 Range Rover Evoque Interior
• Color harmonization across
15 unique color-and-polymer
combinations
• Eliminated need for multiple pre-
colored materials
• Reduced Land Rover’s working
capital
Page 26
KOR Delta Hydration Vessel
• Specialty TPE formulation
overcame performance issues
• Eliminated secondary assembly
process for increased
operational efficiency
Interior
seal
Flip-top
seal
Bottom
ring
Page 27
Friedrich Kühl® Decorative Air Conditioner Housing
• Replaced painted ABS
housing with Geon™ solution
• Reduced operating noise
• Simplified manufacturing
footprint to drive significant
cost savings
Page 28
• Focused on markets with high
growth and profit potential
• Leveraging our in-depth
knowledge of formulation
Focused Efforts in Attractive Industry Segments
$113
$260
Healthcare
and processing to develop
market driven solutions
• Aligning resources across the
organization to drive growth
in target markets $152
$228
2006 2011
Sustainable Solutions
(Revenue in $ millions)
2006 2011
2006 2011
2006 2011
Page 29
• Design service collaboration
• Doubled productivity and
improved yield rates
• Substantial reduction in
overall manufacturing costs
Pulmonary Device
Page 30
Innovating for the future…
Rejuvenate a mature industry with new
products and processes
Products designed for “next life” instead of
“end life”
Plastics: Key to Future Sustainable Development
…Making a difference today!